Ekips Technologies

Norman, United States Founded: 1997 • Age: 29 yrs
Develops laser-based instruments for asthma diagnosis and treatment.

About Ekips Technologies

Ekips Technologies is a company based in Norman (United States) founded in 1997 by Patrick McCann. It operates as a B2B. Ekips Technologies has raised $2.4 million across 2 funding rounds from investors including National Science Foundation and Oklahoma Life Science Fund. Ekips Technologies operates in a competitive market with competitors including Apieron, Eversens, Medipines, Deversify and Spirosure, among others.

  • Headquarter Norman, United States
  • Founders Patrick McCann
  • Sectors
    Healthcare
  • Website ekipstech.com
Operational Areas
Key Metrics

Funding Insights of Ekips Technologies

Ekips Technologies has successfully raised a total of $2.4M across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $2.4 million completed in February 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.4M
  • Total Rounds 2
  • Last Round Unspecified β€” $2.4M
  • First Round $500,000

    (Feb 2006)

  • Investors Count 2

All 2 funding rounds of Ekips Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2006$500,000Grant––
Feb 2006$2.4MUnspecified–Oklahoma Life Science Fund
–
Valuation history

2 investors in total: 2 institutional.

Investors in Ekips Technologies

Ekips Technologies has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include National Science Foundation and Oklahoma Life Science Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Funding is provided to life science companies by OLSF.
–olsfventures.comTulsa, United States
A government-backed foundation providing seed-stage investments to support small businesses.
1950nsf.govArlington, United States
Premium access

Investor details for Ekips Technologies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Ekips Technologies

1 people are tracked at Ekips Technologies (1 in leadership).

NameRoleGroup
Patrick McCann
FounderLeadership
Premium access

Complete people profiles for Ekips Technologies

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Ekips Technologies

2 dated milestones of Ekips Technologies across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Ekips Technologies is founded.
  2. Funding First funding round of $500K.

Competitors of Ekips Technologies

Ekips Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apieron, Eversens, Medipines, Deversify and Spirosure, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
apieron.com2001Menlo Park, United States$68.52M–
Functions as an asthma monitoring device for health management.
eversens.com2015Pamplona, Spain––
Developer of non-invasive diagnostic system to detect bio-markers
medipines.com2014Yorba Linda, United States$2.56M10
Non-invasive respiratory measurement devices are developed for gas exchange assessment.
deversify.com2016Uppsala, Sweden––
Breath analyzers for acetone concentration in exhaled air are developed.
spirosure.com2011Pleasanton, United States$50M12
Non-invasive breathalyzers are developed for pulmonary disease monitoring.
linshomforlife.com2009Ellicott, United States$3.35M–
Developer of respiratory monitoring devices
steradian-tech.com2017Houston, United States––
Developer of a diagnostic device for infectious pathogen detection
dbi.ch2018Risch Rotkreuz, Switzerland$2.85M–
AI and mass spectrometry platforms for personalized medicine are developed.
Premium access

Detailed competitors of Ekips Technologies

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Ekips Technologies

Websites that share an audience with Ekips Technologies (ekipstech.com).

Similar websites

Websites whose visitors overlap most with Ekips Technologies. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ssi-sensors.com
100%
5.5K#3,922,408View details
pranalytica.com
99%
––View details
zolotech.com
99%
––View details
airtest.com
91%
3.5K#5,535,043View details
autonomoustuff.com
49%
4.9K#4,045,277View details

Latest news on Ekips Technologies

Ekips raises $2.9 million
Journalrecord β€’ 20 years ago
Premium access

Complete news archive for Ekips Technologies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Ekips Technologies

10 companies that operate in the same segment as Ekips Technologies (Pulmonology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Portable oxygen concentrators are supplied for respiratory therapy needs.
2001Goleta, California, United StatesUSD 51.65 MUSD 348.67 M766
Cancer detection diagnostics assays are developed and offered.
2005Boulder, Colorado, United StatesUSD 200.16 MUSD 88.5 M273
Therapeutic devices for nasal breathing improvement are developed.
2011Sunnyvale, California, United StatesUSD 176.4 M–66
Non-invasive breath-based diagnostics for cancer and infectious diseases are developed.
2004Cambridge, Cambridgeshire, United KingdomUSD 166.55 M–202
Protein biologics are developed for treating rare diseases.
2005San Diego, California, United StatesUSD 171.52 MUSD 190 K59
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
2008Austin, Texas, United StatesUSD 67.82 M–59
Developer of smart devices for treating pulmonary diseases
1998Redwood City, California, United StatesUSD 280.91 MUSD 90.5 M291
A norovirus vaccine is developed for infection prevention.
2021Boston, Massachusetts, United StatesUSD 135 M–14
Oral small molecule drugs for chronic diseases are developed.
2017San Francisco, California, United StatesUSD 233 M–163
Precision medicines for lung-related diseases are developed.
2015Menlo Park, California, United StatesUSD 371 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Ekips Technologies

Ekips Technologies was founded in 1997 and raised its 1st funding round 9 years after it was founded.

Ekips Technologies is headquartered in Norman, United States. It is registered at Norman, Oklahoma, United States.

Ekips Technologies is a funded company, having raised a total of $2.4M across 2 funding rounds to date. The company's 1st funding round was a Grant of $500K, raised on Feb 2006.

Ekips Technologies develops laser-based instruments for asthma diagnosis and treatment, focusing on providing healthcare solutions, developing medical devices, diagnostic tools, and respiratory health. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

Ekips Technologies's top competitors include Linshom, Medipines and Eversens.

Ekips Technologies has 2 investors. Key investors include National Science Foundation, and Oklahoma Life Science Fund.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available